Responsibilities
Cefuroxime Cefuroxime Inhibits cell-wall Indications: adjust Contraindicated CV: phlebitis: Monitor patient
“Zinacef” 750mg TIV- 90 x 3 synthesis , a dose (for all in patients thrombophlebitis. for signs and
doses promoting indications): For hypersensitive to GI: diarrhea, symptoms of
Classification: osmotic injectable form in drug or other pseudomembran superinfection
Antibiotics instability, usually adults with CrCl cephalosporins. eous colitis, and diarrhea.
bactericidal. of 10 to 20 Use cautiously in nausea, anorexia, Drug may
mL/minute , give patients vomiting. increase INR and
750 mg IV or IM q hypersensitive to Hematologic: risk of bleeding.
12 hrs: if CrCl is penicillin because Hemolytic Monitor Patient.
less than 10 of possibility of anemia, Look alike- Sound
ml/minute, give cross-sensitivity thrombocytopeni Alike: Don’t
750 mg IV or IM with other beta- a, transient confuse drug with
lactam neutropenia, other
antibiotics. eosinophilia. cephalosporins
Skin: that sound alike.
maculopapular Instruct patient to
and notify prescriber
erythematous about rash, loose
rashes, urticaria, stools, diarrhea,
pain, induration, or evidence of
sterile abscesses, superinfection.
temperature Advise pt.
elevation, tissue Receiving drug IV
sloughing at IM to report
injection site. discomfort at IV
insertion site.